Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry launched to study rare lymphoma in women with breast implants

NCT ID NCT04220970

Knowledge-focused Sponsor: The Lymphoma Academic Research Organisation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry is collecting information from women in France and Belgium who have a rare type of lymphoma linked to breast implants. The goal is to learn more about the disease, how it responds to treatment, and how to improve care. No new treatments are being tested; instead, researchers will observe and record outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could help doctors better understand and manage this rare lymphoma, leading to improved treatment guidelines.
What could go wrong
This is an observational registry, not a treatment trial. It collects data only and will not directly test any new therapy or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2017

Expected to finish

Jun 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with an anaplastic large cell lymphoma associated with breast implants

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients with an anaplastic large cell lymphoma associated with breast implants Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anaplastic large cell lymphoma associated with breast implants (bia-alcl) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast implant-associated anaplastic large cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anaplastic large cell lymphoma associated with breast implants (bia-alcl)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    31 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A. Z. Sint-Jan Brugge-Oostende AV

    RECRUITING

    Bruges, Belgium

  • APHP - Hopital Henri Mondor

    RECRUITING

    Créteil, France

  • CH Saint-Eloi

    RECRUITING

    Montpellier, France

  • CH d Avignon - Hopital Henri Duffaut

    RECRUITING

    Avignon, France

  • CH de Pau

    RECRUITING

    Pau, France

  • CH de Perpigan

    RECRUITING

    Perpignan, France

  • CH de Saint Malo

    RECRUITING

    St-Malo, France

  • CHRU de Brest - Hôpital Morvan

    RECRUITING

    Brest, France

  • CHRU de Strasbourg

    RECRUITING

    Strasbourg, 67100, France

  • CHU UCL Namur - Site Godinne

    RECRUITING

    Yvoir, Belgium

  • CHU de Dijon - Hôpital le Bocage

    RECRUITING

    Dijon, 21034, France

  • CHU de Liège -Domaine Sart Tilman

    RECRUITING

    Liège, Belgium

  • CHU de Nantes - Hôtel Dieu

    RECRUITING

    Nantes, France

  • Centre Henri Becquerel

    RECRUITING

    Rouen, France

  • Centre Hospitalier Lyon Sud

    RECRUITING

    Pierre-Bénite, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, France

  • Centre Médical la Roseraie

    RECRUITING

    Lille, France

  • Centre Rene Hugenin

    RECRUITING

    Saint-Cloud, 92210, France

  • Chu de Reims - Hopital Robert Debre

    RECRUITING

    Reims, France

  • Clinique Universitaire Saint LUC

    RECRUITING

    Brussels, Belgium

  • Cliniques Universitaires de Bruxelles - Hôpital Erasme

    NOT_YET_RECRUITING

    Brussels, Belgium

  • Hopital Louis Pasteur

    RECRUITING

    Colmar, France

  • Hôpital Cochin

    RECRUITING

    Paris, France

  • Institut Bergonié

    RECRUITING

    Bordeaux, France

  • Institut Jules Bordet

    RECRUITING

    Brussels, Belgium

  • Institut Paoli Calmettes

    RECRUITING

    Marseille, France

  • Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)

    RECRUITING

    Toulouse, France

  • U.Z. Leuven - Campus Gasthuisberg

    RECRUITING

    Leuven, Belgium

  • Universitair Ziekenhuis Antwerpen

    NOT_YET_RECRUITING

    Edegem, Belgium

  • Universitair Ziekenhuis Brussel

    NOT_YET_RECRUITING

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, Belgium